Study sheds light on cellular resistance to osimertinib in adenocarcinoma
Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now discovered a molecular-level resistance mechanism that begins to take hold as early as six to eight ...
2 minutes ago
0
0









